CN105435251A - Contrast media applicable to cold-heat complication type irritable bowel syndrome - Google Patents
Contrast media applicable to cold-heat complication type irritable bowel syndrome Download PDFInfo
- Publication number
- CN105435251A CN105435251A CN201511021885.4A CN201511021885A CN105435251A CN 105435251 A CN105435251 A CN 105435251A CN 201511021885 A CN201511021885 A CN 201511021885A CN 105435251 A CN105435251 A CN 105435251A
- Authority
- CN
- China
- Prior art keywords
- parts
- liposome
- chinese medicine
- cold
- bowel syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002872 contrast media Substances 0.000 title claims abstract description 26
- 208000002551 irritable bowel syndrome Diseases 0.000 title claims abstract description 13
- 229940039231 contrast media Drugs 0.000 title abstract 4
- 239000002502 liposome Substances 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 21
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 8
- 229940067606 lecithin Drugs 0.000 claims abstract description 8
- 235000010445 lecithin Nutrition 0.000 claims abstract description 8
- 239000000787 lecithin Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000003937 drug carrier Substances 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 7
- 241000220261 Sinapis Species 0.000 claims description 7
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 7
- 230000002496 gastric effect Effects 0.000 abstract description 15
- 230000008855 peristalsis Effects 0.000 abstract description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 3
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 241000183291 Aleuritopteris Species 0.000 abstract 1
- 241000237528 Arcidae Species 0.000 abstract 1
- 241001289295 Asarum sieboldii Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000006463 Brassica alba Nutrition 0.000 abstract 1
- 244000140786 Brassica hirta Species 0.000 abstract 1
- 235000011371 Brassica hirta Nutrition 0.000 abstract 1
- 244000287353 Crassocephalum crepidioides Species 0.000 abstract 1
- 240000008592 Primula malacoides Species 0.000 abstract 1
- 235000002341 Primula malacoides Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 235000021018 plums Nutrition 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 206010000087 Abdominal pain upper Diseases 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000002601 radiography Methods 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-UHFFFAOYSA-N 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 239000006286 aqueous extract Substances 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000003595 mist Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 201000009361 ascariasis Diseases 0.000 description 2
- 210000003445 biliary tract Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 208000018685 gastrointestinal system disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 210000004203 pyloric antrum Anatomy 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 240000003409 Gentiana lutea Species 0.000 description 1
- 235000002873 Gentiana lutea Nutrition 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008828 contractile function Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229940110515 cough out Drugs 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Acoustics & Sound (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicine and particularly relates to contrast media applicable to cold-heat complication type irritable bowel syndrome. The contrast media comprise a liposome and microbubbles wrapped in the liposome, wherein the liposome is prepared from components in parts by weight as follows: 10-25 parts of lecithin and 45-70 parts of a traditional Chinese medicine carrier and is characterized in that the traditional Chinese medicine carrier is prepared from traditional Chinese medicine raw materials in parts by weight as follows: 20-30 parts of dried ginger, 20-30 parts of asarum sieboldii, 10-15 parts of white mustard, 10-15 parts of rhizoma coptidis, 20-30 parts of Primula malacoides, 10-15 parts of Aleuritopteris hopeana (C. Chr.) Ching, 10-15 parts of manyprickle acanthopanax root, 10-15 parts of Gynura crepidioides Benth., 10-15 parts of stir-fried white atractylodes rhizome, 10-15 parts of immature orange fruit, 10-15 parts of calcined ark shells and 5-10 parts of smoked plums. The contrast media have the advantages of inhibition of too fast gastrointestinal peristalsis and nourishment of the gastrointestinal tract.
Description
Technical field
The invention belongs to field of traditional Chinese medicine technology, relate to a kind of gastrointestinal tract contrast medium, be specifically related to a kind of contrast agent being applicable to intermingling cold and heat type irritable bowel syndrome.
Background technology
Gastrointestinal tract is hollow organ, often has gases affect, and ultrasonic detection from body surface is difficult to obtain satisfied ultrasonogram, and the diagnosis of gastroenteropathy often relies on gastroscope and the barium meal examination of x line.In recent years due to development and the application of gastrointestinal acoustic contrast art and ultrasonic endoscope two technology, widen the diagnostic area of gastrointestinal disease.Ultrasonic examination can the hierarchical structure of clear display gastrointestinal wall, find the position of gastrointestinal wall tumor, size and geometric, estimate that pathological changes invades the degree of gastrointestinal wall, particularly understand the transfer case of peripheral organs, make up the deficiency of gastroscope and x ray examination, the selection for clinical treatment provides reliable foundation.
Wherein, gastro intestinal ultrasonic contrast examination method adopts contrast agent to fill stomach, enteric cavity, by improving the ultrasonic internal medium of gastrointestinal, being beneficial to ultrasonic wave acoustic beam and penetrating, and gastrointestinal structure and its pathological changes are conveniently shown more clearly.
But suffering from the patient of irritable bowel syndrome when taking contrast agent, often there will be the situation that contrast agent one or two hour has just arrived ileocecus, normal condition should at three to six hours, thus can not radiography smoothly.There is this situation normally because gastrointestinal peristalsis is too fast, accelerate contrast agent displacement.Therefore, for this class patient in angiographic procedure can gastrointestinal peristalsis inhibition too fast, and can radiography smoothly, become problem demanding prompt solution.
Summary of the invention
The object of this invention is to provide a kind of contrast agent being applicable to intermingling cold and heat type irritable bowel syndrome, have gastrointestinal peristalsis inhibition too fast, nourish gastrointestinal advantage.
The symptom of intermingling cold and heat type irritable bowel syndrome is: have a pain in abdomen or borborygmus diarrhoea, just lower sticky smooth, or folder foam, or diarrhoea and constipation are handed over and done, unhappy loss of appetite, gastral cavity abdomen pain relieved by pressing, xerostomia.Red tongue, greasy fur, stringy and rolling pulse.Concrete reason is analyzed as follows: prolonged illness is lost and controlled or natural endowment difference, and cause coldheat complex, cold-evil stays in the intestines and stomach, then have a pain in abdomen, and borborygmus are suffered from diarrhoea, just lower sticky not smooth, even folder foam; Coldheat complex, disorder of movement of QI, therefore see that diarrhoea and constipation are handed over and done; Pathogenic heat more very time visible xerostomia, unhappy loss of appetite, cold-evil's impairment of YANG, then gastral cavity abdomen likes warm pain relieved by pressing, red tongue greasy fur, and stringy and rolling pulse is that cold and heat cherish assorted levying.Therefore, the present invention proposes following technical scheme.
The invention provides a kind of contrast agent being applicable to intermingling cold and heat type irritable bowel syndrome, be made up of liposome and the microvesicle be wrapped in described liposome, described liposome is made up of the component of following weight portion: 10 ~ 25 parts, lecithin, middle drug carrier 45 ~ 70 parts; It is characterized in that described middle drug carrier is formulated by the raw material of Chinese medicine of following parts by weight: Rhizoma Zingiberis 20 ~ 30 parts, Herba Asari 20 ~ 30 parts, Caulis et Folium Sinapis albee 10 ~ 15 parts, Rhizoma Coptidis 10 ~ 15 parts, Flos Primulae Vittatae 20 ~ 30 parts, little tackle all problems at once 10 ~ 15 parts, Radix Et Caulis Acanthopanacis Senticosi 10 ~ 15 parts, exist everywhere 10 ~ 15 parts, Rhizoma Atractylodis Macrocephalae (parched) 10 ~ 15 parts, Fructus Aurantii Immaturus 10 ~ 15 parts, Concha Arcae (calcined) 10 ~ 15 parts, Fructus Mume 5 ~ 10 parts.
The gas of filling in described microvesicle is the oxygen of volume ratio 4 ~ 8: 1 and the mist of carbon dioxide composition.
Wherein, preferred version is as follows:
Described contrast agent is made up of liposome and the microvesicle be wrapped in described liposome, and described liposome is made up of the component of following weight portion: 20 parts, lecithin, middle drug carrier 55 parts; It is characterized in that described middle drug carrier is formulated by the raw material of Chinese medicine of following parts by weight: Rhizoma Zingiberis 25 parts, Herba Asari 25 parts, Caulis et Folium Sinapis albee 12 parts, Rhizoma Coptidis 12 parts, Flos Primulae Vittatae 25 parts, little tackle all problems at once 12 parts, Radix Et Caulis Acanthopanacis Senticosi 12 parts, exist everywhere 12 parts, Rhizoma Atractylodis Macrocephalae (parched) 12 parts, Fructus Aurantii Immaturus 12 parts, Concha Arcae (calcined) 12 parts, Fructus Mume 8 parts.
Contrast agent preparation method of the present invention is as follows:
(1) get above-mentioned raw material of Chinese medicine by weight to pulverize, cross 40 ~ 80 mesh sieves, add the distilled water of mixing Chinese medicine powder quality 4 ~ 8 times, decoct 1 ~ 2h, filter, obtain Aqueous extracts filtrate, Aqueous extracts concentrating under reduced pressure obtains water extracting liquid, 95% ethanol of its quality 3 ~ 4 times is added in residue, reflux 2 ~ 3h, extract 2 ~ 3 times, merge extractive liquid, filter, obtain alcohol extract, alcohol extract concentrating under reduced pressure, be recycled to without alcohol taste, mix with the water extracting liquid obtained above, further concentrating under reduced pressure, except desolventizing, dry, obtain and get dry extract, dry cream is placed in super micron mill to be pulverized, sieve, obtain 800 ~ 1000 object micropowders,
(2) join in dehydrated alcohol by lecithin, stirring and dissolving at 37 ~ 42 DEG C, add the Chinese crude drug micropowders that step (1) obtains in the solution obtained, rotary evaporation volatilizes solvent and obtains pro-liposome;
(3) aseptically, the pro-liposome that taking-up (2) obtains is sub-packed in cillin bottle, and the mist then injecting oxygen and carbon dioxide composition, to replace the air of cillin bottle head, seals and get final product.
Pharmacology analysis:
Rhizoma Zingiberis: pungent, hot.Return spleen, stomach, kidney, the heart, lung meridian.Rhizoma Zingiberis warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, dampness expectorant.For coldness and pain in the epigastrium, vomiting is had loose bowels, and cold extremities faint pulse, phlegm retention is breathed with cough.
Herba Asari: pungent, temperature.GUIXIN, lung, kidney channel.Expelling wind and cold, understand things pain-stopping, warming the lung to resolve fluid-retention.For anemofrigid cold, headache, toothache, nasal obstruction nasal sinusitis, rheumatic arthralgia, phlegm retention is breathed with cough.
Caulis et Folium Sinapis albee: acrid in the mouth, temperature, nontoxic.Enter lung.Warming spleen and stomach for dispelling cold.Control cough out of breath, stomach, abdomen cold type of pain.
Rhizoma Coptidis: bitter, cold.GUIXIN, spleen, stomach, liver, gallbladder, large intestine channel.Heat clearing and damp drying, eliminating fire and detoxication.For damp and hot feeling of fullness, vomiting acid regurgitation, dysentery, jaundice, unconsciousness due to high fever, hyperactivity of heart-fire, dysphoria and insomnia, heat in blood tells nosebleed, conjunctival congestion, and toothache, quenches one's thirst, carbuncle furuncle; External treatment eczema, eczema, auditory meatus is suppurated.
Flos Primulae Vittatae: bitter, cold.Heat clearing and damp drying, eliminating pathogen in the liver gallbladder fire, hemostasis.Control infantile hyperpyrexia convulsion, acute gastroenteritis, dysentery.
Littlely to tackle all problems at once: light, flat.Strengthening the spleen and stomach, invigorating the spleen and replenishing QI.Cure mainly flu, infantile malnutrition, the old deficiency of vital energy.
Radix Et Caulis Acanthopanacis Senticosi: pungent, micro-hardship, temperature.Return spleen, kidney, heart channel.Replenishing QI to invigorate the spleen, tonifying the kidney for tranquilization.For deficiency of spleen-YANG and kidneyYANG, body void is weak, inappetence, soreness of waist and knee joint, insomnia and dreamful sleep.
Exist everywhere: bitter, micro-pungent, flat.Spleen strengthening and bloatedness reducing.For dyspepsia, insufficiency of the spleen edema.
Rhizoma Atractylodis Macrocephalae (parched): there is invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive effect.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.
Fructus Aurantii Immaturus: bitter; Pungent; Cold.Return spleen; Stomach; Liver; Heart channel.Effect: stop in stagnant; Feeling of fullness distending pain; Constipation; Heavy after dysentery; Blocked-up chest; Gastroptosis; Uterine prolapse; Proctoptosis.
Concha Arcae (calcined): salty is flat.Return lung, stomach, Liver Channel.Expectorant blood stasis dispelling, hard masses softening and resolving, relieving gastric hyperacidity to alleviate stomachache.For the long-pending knot of pertinacious phlegm, sticky difficulty is coughed up, goiter, scrofula, lump in the abdomen mass in the abdomen, stomachache pantothenic acid.
Fructus Mume: sour, puckery is flat.Return liver, spleen, lung, large intestine channel.Astringe the lung, astringing intestine to stop diarrhea, promotes the production of body fluid, relieving colic caused by ascaris.For chronic cough of deficiency lung, chronic dysentery laxation, deficiency-heat is quenched one's thirst, ascariasis of biliary tract vomiting stomachache, ascariasis of biliary tract.
In the present invention, during Rhizoma Zingiberis, Herba Asari, Caulis et Folium Sinapis albee warming YANG to expel cold warm up; Rhizoma Coptidis, Flos Primulae Vittatae heat clearing and damp drying; Littlely to tackle all problems at once, Radix Et Caulis Acanthopanacis Senticosi, invigorating the spleen and benefiting QI of existing everywhere; Rhizoma Atractylodis Macrocephalae (parched), Fructus Aurantii Immaturus, Concha Arcae (calcined) nourishing the stomach, play nourishing effect to stomach; Fructus Mume sour and sweet drugs can transforme into YIN, all medicines of mediation cold and heat.
Drug carrier sheerly Chinese medicine preparation in the present invention, prove through years of researches and clinical practice: drug safety is reliable, medicine valency is cheap, carry taking convenience, avoid toxic and side effects and the anaphylaxis of chemicals, be applicable to intermingling cold and heat type irritable bowel syndrome patient, and to stomach tool Yellow Gentian Extract.
Outcome measure:
Take effect: without senses of discomfort such as stomachache, vomitings, radiography is clear, start to discharge contrast agent in 3 ~ 6 hours after checking.
Take a turn for the better: the senses of discomfort such as stomachache, vomiting alleviate, and radiography is clear, start to discharge contrast agent in 2 ~ 3 hours after checking.
Invalid: all diseases are not improved, namely contrast agent arrives ileocecus in 1 ~ 2 hour.
Take result: check patient 50 example, be intermingling cold and heat type irritable bowel syndrome patient, the made contrast agent of the present invention that swallows, if feel stimulating gastrointestinal road, have the gastric lavage immediately of allergic symptom emetic.After inspection, take effect 35 examples, accounts for 70%, and take a turn for the better 15 examples, accounts for 30%.
An attached routine case is described further:
Case 1: finish certain, female, 42 years old, civil servant.The regular pain of the intestines and stomach, does ultrasonic contrast at the beginning, and within 2 hours, contrast agent arrives ileocecus, fails smooth radiography.Take contrast agent of the present invention to check, occur without stomachache, vomiting situation, radiography is clear, and stomach is fishhook-type, on an empty stomach without stomach pool stream; Antrum pleat irregular arrangement, increases thick.Gastric antrum community and stomach ditch plumpness, have no clear and definite ridge shadow and filling defect.Gastric antrum is little curved in dentation, and wriggle, contractile function is on the weak side; Without tenderness excitation.Check latter 3 hours namely to start to discharge contrast agent.
Detailed description of the invention
Embodiment 1:
The present embodiment provides a kind of contrast agent being applicable to intermingling cold and heat type irritable bowel syndrome, and be made up of liposome and the microvesicle be wrapped in described liposome, described liposome is made up of the component of following weight portion: 20 parts, lecithin, middle drug carrier 55 parts; Described middle drug carrier is formulated by the raw material of Chinese medicine of following parts by weight: Rhizoma Zingiberis 25 parts, Herba Asari 25 parts, Caulis et Folium Sinapis albee 12 parts, Rhizoma Coptidis 12 parts, Flos Primulae Vittatae 25 parts, little tackle all problems at once 12 parts, Radix Et Caulis Acanthopanacis Senticosi 12 parts, exist everywhere 12 parts, Rhizoma Atractylodis Macrocephalae (parched) 12 parts, Fructus Aurantii Immaturus 12 parts, Concha Arcae (calcined) 12 parts, Fructus Mume 8 parts.
Described contrast agent preparation method is as follows:
(1) get above-mentioned raw material of Chinese medicine by weight to pulverize, cross 60 mesh sieves, add the distilled water of mixing Chinese medicine powder quality 5 times, decoct 1h, filter, obtain Aqueous extracts filtrate, Aqueous extracts concentrating under reduced pressure obtains water extracting liquid, 95% ethanol of its quality 4 times is added in residue, reflux 3h, extract 2 times, merge extractive liquid, filter, obtain alcohol extract, alcohol extract concentrating under reduced pressure, be recycled to without alcohol taste, mix with the water extracting liquid obtained above, further concentrating under reduced pressure, except desolventizing, dry, obtain and get dry extract, dry cream is placed in super micron mill to be pulverized, sieve, obtain 1000 object micropowders,
(2) join in dehydrated alcohol by lecithin, stirring and dissolving at 40 DEG C, add the Chinese crude drug micropowders that step (1) obtains in the solution obtained, rotary evaporation volatilizes solvent and obtains pro-liposome;
(3) aseptically, the pro-liposome that taking-up (2) obtains is sub-packed in cillin bottle, and the mist then injecting oxygen and carbon dioxide composition, to replace the air of cillin bottle head, seals and get final product.
Claims (2)
1. be applicable to a contrast agent for intermingling cold and heat type irritable bowel syndrome, be made up of liposome and the microvesicle be wrapped in described liposome, described liposome is made up of the component of following weight portion: 10 ~ 25 parts, lecithin, middle drug carrier 45 ~ 70 parts; It is characterized in that described middle drug carrier is formulated by the raw material of Chinese medicine of following parts by weight: Rhizoma Zingiberis 20 ~ 30 parts, Herba Asari 20 ~ 30 parts, Caulis et Folium Sinapis albee 10 ~ 15 parts, Rhizoma Coptidis 10 ~ 15 parts, Flos Primulae Vittatae 20 ~ 30 parts, little tackle all problems at once 10 ~ 15 parts, Radix Et Caulis Acanthopanacis Senticosi 10 ~ 15 parts, exist everywhere 10 ~ 15 parts, Rhizoma Atractylodis Macrocephalae (parched) 10 ~ 15 parts, Fructus Aurantii Immaturus 10 ~ 15 parts, Concha Arcae (calcined) 10 ~ 15 parts, Fructus Mume 5 ~ 10 parts.
2. be applicable to the contrast agent of intermingling cold and heat type irritable bowel syndrome as claimed in claim 1, be made up of liposome and the microvesicle be wrapped in described liposome, described liposome is made up of the component of following weight portion: 20 parts, lecithin, middle drug carrier 55 parts; It is characterized in that described middle drug carrier is formulated by the raw material of Chinese medicine of following parts by weight: in Rhizoma Zingiberis Recens 25 parts, Herba Asari 25 parts, Caulis et Folium Sinapis albee 12 parts, Rhizoma Coptidis 12 parts, Flos Primulae Vittatae 25 parts, little tackle all problems at once 12 parts, Radix Et Caulis Acanthopanacis Senticosi 12 parts, exist everywhere 12 parts, Rhizoma Atractylodis Macrocephalae (parched) 12 parts, Fructus Aurantii Immaturus 12 parts, Concha Arcae (calcined) 12 parts, Fructus Mume 8 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511021885.4A CN105435251A (en) | 2015-12-23 | 2015-12-23 | Contrast media applicable to cold-heat complication type irritable bowel syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511021885.4A CN105435251A (en) | 2015-12-23 | 2015-12-23 | Contrast media applicable to cold-heat complication type irritable bowel syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105435251A true CN105435251A (en) | 2016-03-30 |
Family
ID=55546167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511021885.4A Pending CN105435251A (en) | 2015-12-23 | 2015-12-23 | Contrast media applicable to cold-heat complication type irritable bowel syndrome |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105435251A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102861306A (en) * | 2012-09-06 | 2013-01-09 | 李承平 | Group of dark plum fruit combined tablets |
CN104857533A (en) * | 2015-05-29 | 2015-08-26 | 乔芳霞 | Ultrasonic diagnosis contrast medium and preparation method thereof |
CN104984366A (en) * | 2015-08-11 | 2015-10-21 | 刘子成 | Gastrointestinal tract contrast agent |
CN105031670A (en) * | 2015-08-11 | 2015-11-11 | 青岛市中心医院 | Gastrointestinal tract contrast agent |
-
2015
- 2015-12-23 CN CN201511021885.4A patent/CN105435251A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102861306A (en) * | 2012-09-06 | 2013-01-09 | 李承平 | Group of dark plum fruit combined tablets |
CN104857533A (en) * | 2015-05-29 | 2015-08-26 | 乔芳霞 | Ultrasonic diagnosis contrast medium and preparation method thereof |
CN104984366A (en) * | 2015-08-11 | 2015-10-21 | 刘子成 | Gastrointestinal tract contrast agent |
CN105031670A (en) * | 2015-08-11 | 2015-11-11 | 青岛市中心医院 | Gastrointestinal tract contrast agent |
Non-Patent Citations (2)
Title |
---|
夏翔 等主编.: "《一百天学中医内科》", 31 July 2001, 上海科学技术出版社 * |
戴晓兰,徐进康.: "肠易激综合征的中医研究进展", 《河北中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103169862A (en) | Traditional Chinese medicine formula for treating vital myocarditis | |
CN103495187B (en) | Type-B ultrasonic traditional Chinese medicinal gastroenterography assistant and method for preparing same | |
CN105362650A (en) | Pharmaceutical composition for treating constipation and application method thereof | |
CN102935242A (en) | Traditional Chinese medicine-assisted imaging preparation for ultrasonic image diagnosis, and preparation method thereof | |
CN104922639A (en) | Traditional Chinese medicine stomach-nourishing pill and preparation method thereof | |
CN103272189B (en) | Medicine for curing gallstones | |
CN105688006A (en) | Traditional Chinese medicine composition for treating hemiplegia and preparation method thereof | |
CN103028093B (en) | Traditional Chinese medicine composition for treating chronic obstructive pulmonary emphysema and preparation method of traditional Chinese medicine composition | |
CN105106872A (en) | Traditional Chinese medicine composition for treating coronary heart diseases and preparation method of traditional Chinese medicine composition | |
CN109200170A (en) | A kind of Chinese materia medica preparation that treating intractable constipation and preparation method | |
CN103690869B (en) | Chinese medicine for the treatment of irritable bowel syndrome and preparation method thereof | |
CN105435251A (en) | Contrast media applicable to cold-heat complication type irritable bowel syndrome | |
CN103610893B (en) | A kind of Chinese medicine for the treatment of coronary heart disease | |
CN105477649A (en) | Contrast medium for cold-heat complication type irritable bowel syndrome | |
CN105106802A (en) | Traditional Chinese medicine composition for treating peripheral facial paralysis | |
CN104398748A (en) | Traditional Chinese medicine for treating nephritis | |
CN105213901B (en) | A kind of gout suppressant compositions, its application and preparation method | |
CN105435252A (en) | Contrast medium applicable to cold-heat complication type irritable bowel syndrome | |
CN103656353B (en) | A kind of pharmaceutical composition and application thereof for the treatment of pulmonary abscess | |
CN103285130B (en) | Chinese medicine composition for liver cancer treatment and preparing method thereof | |
CN105617409A (en) | Contrast agent suitable for cold-heat complication type irritable bowel syndrome | |
CN106266730A (en) | One treats emophysematous Chinese medicine composition and preparation method thereof | |
CN105920557A (en) | Tablet capable of treating gastrointestinal diseases and preparation method of tablet | |
CN104840765A (en) | Drug for treating senile constipation | |
CN105536001A (en) | Contrast agent suitable for liver stagnation and spleen insufficiency type irritable bowel syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160330 |